The revised 2009 FIGO staging system for endometrial cancer: Should the 1988 FIGO stages IA and IB be altered?

International Journal of Gynecological Cancer

Volumn 21, Issue 3, 2011, Pages 511-516

  Abu Rustum, Nadeem R ^a   Zhou, Qin ^a   Iasonos, Alexia ^a   Alektiar, Kaled M ^a   Leitao Jr , Mario M ^a   Chi, Dennis S ^a   Sonoda, Yukio ^a   Soslow, Robert ^a   Hensley, Martee ^a   Barakat, Richard R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

2009 FIGO staging system; Endometrial cancer; Overall survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; ENDOMETRIUM CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NOMOGRAM; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; CLASSIFICATION; ENDOMETRIUM TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; STANDARD; SURVIVAL RATE; TIME;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 79960076210     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31820cc305     Document Type: Article

References (16)

1. Boronow RC, Morrow CP, Creasman WT, et al. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol. 1984;63:825-832. (Pubitemid 14105231)
2. Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987;60: 2035-2041. (Pubitemid 17145924)
3. DiSaia PJ, Creasman WT. Management of endometrial adenocarcinoma stage I with surgical staging followed by tailored adjuvant radiation therapy. Clin Obstet Gynaecol. 1986;13:751-765. (Pubitemid 17209387)
4. Gonen M, Heller G. Concordance probability and discriminatory power in proportional hazards regression. Biometrika. 2005;92:965-970. (Pubitemid 41681247)
5. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387. (Pubitemid 26072233)
6. Odicino F, Pecorelli S, Zigliani L, et al. History of the FIGO cancer staging system. Int J Gynaecol Obstet. 2008;101:205-210.
7. Homesley HD, Boronow RC, Lewis JL Jr. Treatment of adenocarcinoma of the endometrium at Memorial-James Ewing Hospitals, 1949-1965. Obstet Gynecol. 1976;47:100-105.
8. Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991; 40:55-65.
9. DiSaia PJ, Creasman WT, Boronow RC, et al. Risk factors and recurrent patterns in Stage I endometrial cancer. Am J Obstet Gynecol. 1985;151:1009-1015. (Pubitemid 15039768)
10. Boronow RC. Endometrial cancer and surgical staging: a personal assessment. Philipp J Obstet Gynecol. 1998;22:71-77.
11. Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet. 2009;105:109.
12. Mutch DN. The new FIGO staging system for cancers of the vulva, cervix, endometrium and sarcomas. Gynecol Oncol. 2009;115:325-328.
13. Pecorelli S. Revised FIGO staging of carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Obstet. 2009;105: 103-104.
14. Kim HS, Song YS. International Federation of Gynecology and Obstetrics (FIGO) staging system revised: what should be considered critically for gynecologic cancer? J Gynecol Oncol. 2009;20:135-136.
15. Ben-Porat L, Panageas KS, Hanlon C, et al. Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma. Cancer. 2006;106:163-171. (Pubitemid 43032561)
16. Lewin SN, Herzog TJ, Barrena Medel NI, et al. Comparative performance of the 2009 International Federation of Gynecology and Obstetrics' staging system for uterine corpus cancer. Obstet Gynecol. 2010;116: 1141-1149.